Sunwels Co.,Ltd.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Sunwels Co.,Ltd.'s yearly results (2023–2026), compared with Healthcare companies in Japan. Tap ? on any ratio for what it means.
What stands out
- Cash Cushion Ratio: Debt, after subtracting cash, is 6.5 times its market value (net debt). Lower than almost all Healthcare companies in Japan.
- Tangible Assets Ratio: Of every ¥100 the company owns, ¥100 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles. More tangible than 94% of Healthcare companies in Japan.
- Tangible Net Worth Ratio: Of every ¥100 of net worth, ¥100 is tangible; the rest is goodwill and other intangibles, often from buying other companies. More tangible than 91% of Healthcare companies in Japan.
Where ¥100 of sales goes
Latest year (Mar 2026). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
0.4×Over the last 3 years its own operating cash paid for 38% of its investment spending (capex); the rest came from other sources such as borrowing, cash reserves or new shares.
Lower than 72% of Healthcare companies in Japan.
Cash Locked Ratio
¥6For every ¥100 of sales, ¥6 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against ¥10 tied up three years earlier.
Less money tied up than 70% of Healthcare companies in Japan.
Growth quality
Steadiness Ratio
3/3 · 1/3Sales grew in 3 of the last 3 years; profit grew in 1 of 3.
Less steady than 55% of Healthcare companies in Japan.
Growth Efficiency Ratio
−¥17Sales grew 105% in 3 years, but profit fell: ¥17 less profit per ¥100 of extra sales.
Lower than 87% of Healthcare companies in Japan.
Asset Productivity Ratio
+105% / +138%In 3 years sales changed by +105% while total assets changed by +138%. Assets grew faster than sales.
Balance-sheet strength
Debt Due Cover Ratio
-0.2×Operating cash was negative last year, while some debt falls due within a year.
Lower than 82% of Healthcare companies in Japan.
Cash Cushion Ratio
6.5× debtDebt, after subtracting cash, is 6.5 times its market value (net debt).
Lower than almost all Healthcare companies in Japan.
Tangible Assets Ratio
100%Of every ¥100 the company owns, ¥100 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
More tangible than 94% of Healthcare companies in Japan.
Tangible Net Worth Ratio
100%Of every ¥100 of net worth, ¥100 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
More tangible than 91% of Healthcare companies in Japan.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (13)
Sunwels Co.,Ltd. made a loss over the last year. Sunwels Co.,Ltd. owes ¥0.86 for every ¥1 it owns. Sunwels Co.,Ltd. made a loss in each of the last two years.
Compared with Healthcare companies in Japan · latest annual results Mar 2026.
P/E ratio
LossSunwels Co.,Ltd. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
0.57The share price is 0.57 times Sunwels Co.,Ltd.'s book value per share, lower than 96% of Healthcare companies in Japan.
Market cap
¥3.6 BThe total market value of all of Sunwels Co.,Ltd.'s shares at today's price (share price × number of shares), smaller than 86% of Healthcare companies in Japan. PosiCap size class: Micro Cap.
Net worth (book value)
¥6.4 BWhat Sunwels Co.,Ltd. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
¥197.92Net worth divided by the number of shares. The share price of ¥112.00 is 0.6 times this, which is the P/B above.
Return on equity (ROE)
-20.8%Sunwels Co.,Ltd. lost 20.8% of its shareholders' money over the last year, lower than 81% of Healthcare companies in Japan.
Owes vs Owns
0.86×Sunwels Co.,Ltd. owes ¥0.86 for every ¥1 it owns (high), higher than 95% of Healthcare companies in Japan.
Dividend yield
NoneSunwels Co.,Ltd. does not currently pay a dividend.
Revenue growth
+6%Revenue rose 6% in the year to Mar 2026, and grew 27% a year on average over 3 years.
Profit growth
LossSunwels Co.,Ltd. made a loss in each of the last two years.
Profit margin
-5.9%Sunwels Co.,Ltd. lost ¥6 for every ¥100 of revenue.
Interest cover
Not coveredSunwels Co.,Ltd.'s operating profit did not cover its interest costs in the year to Mar 2026.
Cash vs debt
Net debtSunwels Co.,Ltd. had ¥25.0 B more debt than cash (net debt) at Mar 2026.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Sunwels Co.,Ltd.: ¥3.6 B ÷ ¥6.4 B (30 Jun 2026) = 0.6.
What is Sunwels Co.,Ltd.'s return on equity?
Sunwels Co.,Ltd. lost 20.8% of its shareholders' money over the last year, lower than 81% of Healthcare companies in Japan.
How much does Sunwels Co.,Ltd. owe compared with what it owns?
Sunwels Co.,Ltd. owes ¥0.86 for every ¥1 it owns (high), higher than 95% of Healthcare companies in Japan.
Does Sunwels Co.,Ltd. pay a dividend?
No. Sunwels Co.,Ltd. does not currently pay a dividend.
Is Sunwels Co.,Ltd.'s revenue growing?
Revenue rose 6% in the year to Mar 2026, and grew 27% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.